Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine

Acta Haematol. 2003;109(2):110. doi: 10.1159/000068493.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Hypergammaglobulinemia
  • Immunoblastic Lymphadenopathy / complications*
  • Immunoblastic Lymphadenopathy / drug therapy*
  • Lymphoma, T-Cell / complications*
  • Lymphoma, T-Cell / drug therapy*
  • Middle Aged
  • Remission Induction
  • Vidarabine / analogs & derivatives*
  • Vidarabine / therapeutic use*

Substances

  • Antineoplastic Agents
  • Vidarabine
  • fludarabine